See the Complete Picture.
Published loading...Updated

High Times for German Cannabis Firm Amid Medical Boom

  • Cantourage, a pharmaceutical company based in Bavaria, produces and distributes cannabis-based medicinal products amid Germany's partial cannabis legalization.
  • Last year's partial legalization and eased prescription rules by the former centre-left government triggered a surge in demand and debates over future regulations.
  • Cantourage operates under strict safety standards inside a secured Bavarian facility, processing dried cannabis flowers sourced from Jamaica, Uganda, and New Zealand.
  • The company recorded 51.4 million euros revenue in 2024, a 118 percent increase from 2023, and employs 70 staff while trading under ticker 'HIGH' on Frankfurt Stock Exchange.
  • Chancellor Merz’s coalition supports an open-ended evaluation of cannabis laws, with Cantourage’s CEO relaxed about regulatory risks and hopeful for full legalization progress.
Insights by Ground AI
Does this summary seem wrong?

55 Articles

All
Left
6
Center
14
Right
9
charitonleader.comcharitonleader.com
+53 Reposted by 53 other sources
Center

High times for German cannabis firm amid medical boom

At an undisclosed site in Germany's Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimetre (30-inch) thick steel door that secures his wares: vast amounts of cannabis.

·Chariton, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 48% of the sources are Center
48% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KULR-TV broke the news in Billings, United States on Sunday, May 18, 2025.
Sources are mostly out of (0)